{arrow_up} Back to top

Risk Minimisation Materials

Search by company, common medicine name, or title of Risk Minimisation Material

0-9 ABCDEFGHIJKLMNOPQRSTUVWXYZ

Fabhalta

Novartis Pharmaceuticals UK Ltd

{pdf_link}

FABHALTA - Vaccination Confirmation Form

{healthcare_pro_orange} For Healthcare Professionals
Part of the Controlled Access, this Vaccination Confirmation Form verifies that iptacopan can only be dispensed once Novartis receives written confirmation that each patient has received vaccination against N. meningitidis and S. pneumoniae infections and/or receipt of prophylactic antibiotic treatment (in accordance with national guidelines).
{pdf_link}

FABHALTA Patient safety card

This material has been developed and funded by Novartis Pharmaceuticals UK Ltd and is intended only for UK patients with paroxysmal nocturnal haemoglobinuria (PNH) who have been prescribed iptacopan.
{pdf_link}

Healthcare Professional’s Guide to FABHALTA

{healthcare_pro_orange} For Healthcare Professionals
This brochure aims to provide guidance and mitigate possible risk of infections during iptacopan treatment, and haemolysis after discontinuation.
{pdf_link}

Patient and caregiver guide to treatment with FABHALTA

This material has been developed and funded by Novartis Pharmaceuticals UK Ltd and is intended only for UK patients with paroxysmal nocturnal haemoglobinuria (PNH) who have been prescribed iptacopan and their caregivers. This guide aims to provide you with important safety information for iptacopan.

Fabrazyme

SANOFI

{pdf_link}

Fabrazyme (agalsidase beta) - Home Infusion HCP Manual - Risk Minimisation Information for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals
The objective of this document is to provide guidance to healthcare professionals for the management of patients receiving Fabrazyme (agalsidase beta) at home. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]
{pdf_link}

Fabrazyme (agalsidase beta) - Home Infusion Patient Manual - Risk Minimisation Information for Patients

The objective of this document is to provide patients with guidance on how to receive Fabrazyme (agalsidase beta) at home. It is the responsibility of the treating physician to supply this material to patients only if the treating physician decides that the patient is eligible for home infusion treatment. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]
{pdf_link}

Fabrazyme (agalsidase beta)Home Infusion Patient Logbook- Risk Minimisation Information for Patients

For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

Farydak

pharmaand GmbH

{pdf_link}

Farydak patient card cycles 1-8

Compliance card to keep track of the Farydak regimen
{pdf_link}

Farydak patient card cycles 9-16

Compliance card to keep track of Farydak regimen

Femodene

Bayer plc

{pdf_link}

CHCs - Checklist for Prescribers

{healthcare_pro_orange} For Healthcare Professionals
Combined Hormonal Contraceptives - checklist for prescribers
{pdf_link}

CHCs - Q&A on Important Info for Women

Combined hormonal contraceptives: Q&As about the important information for women.
{pdf_link}

CHCs - Risk of Blood Clots with CHCs

Important Information for women about risk of blood clots with combined hormonal contraceptives.

Femodene ED

Bayer plc

{pdf_link}

CHCs - Checklist for Prescribers

{healthcare_pro_orange} For Healthcare Professionals
Combined Hormonal Contraceptives - checklist for prescribers
{pdf_link}

CHCs - Q&A on Important Info for Women

Combined hormonal contraceptives: Q&As about the important information for women.
{pdf_link}

CHCs - Risk of Blood Clots with CHCs

Important Information for women about risk of blood clots with combined hormonal contraceptives.

Femodette

Bayer plc

{pdf_link}

CHCs - Checklist for Prescribers

{healthcare_pro_orange} For Healthcare Professionals
Combined Hormonal Contraceptives - checklist for prescribers
{pdf_link}

CHCs - Q&A on Important Info for Women

Combined hormonal contraceptives: Q&As about the important information for women.
{pdf_link}

CHCs - Risk of Blood Clots with CHCs

Important Information for women about risk of blood clots with combined hormonal contraceptives.

Fenapin

Galvany Pharma Ltd

{pdf_link}

Fenapin 20 mg/ml Solution for Infusion Card

{healthcare_pro_orange} For Healthcare Professionals
Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Fenhuma

Glenmark Pharmaceuticals Europe Ltd

{pdf_link}

Important risk minimisation information for healthcare professionals about treatment on Fenhuma

{healthcare_pro_orange} For Healthcare Professionals

The Fenhuma® Prescriber Guide is designed to support healthcare professionals

in the diagnosis of breakthrough pain (BTP) in patients suffering from cancer. It

provides guidance on the initiation, administration and titration of Fenhuma ® and

promotes engagement with patients and their carers. The booklet should be

used in conjunction with the Fenhuma ® Summary of Product Characteristics

(SPC).

{pdf_link}

Important risk minimisation information for patients and their carers about treatment on Fenhuma

Booklet - Important risk minimisation information for patients and their carers

Fibrovein

STD Pharmaceutical Products Ltd

{pdf_link}

Guide for healthcare professionals on the safe use of Fibrovein

{healthcare_pro_orange} For Healthcare Professionals
Guide describes key safety concerns and how to avoid them

Finasteride

Amarox Limited

{pdf_link}

Finasteride- Patient Alert Card for 1mg

Finasteride- Patient Alert Card for 1mg

{pdf_link}

Finasteride- Patient Alert Card for 5 mg

Finasteride- Patient Alert Card for 5mg

Aurobindo Pharma - Milpharm Ltd.

{pdf_link}

Patient Alert Card for Finasteride 1 mg film-coated tablets

{healthcare_pro_orange} For Healthcare Professionals
Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care.
{pdf_link}

Patient Alert Card for Finasteride 5 mg film-coated tablets

{healthcare_pro_orange} For Healthcare Professionals
Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care.

Cipla EU Ltd

{pdf_link}

Finasteride - Patient Alert Card

Patient Alert Card

Dr. Reddy's Laboratories (UK) Ltd

{pdf_link}

Finasteride-Patient Alert Card

Finasteride-Patient Alert Card

Strandhaven Limited t/a Somex Pharma

{pdf_link}

Finasteride - Patient alert card

Patient alert card

{pdf_link}

Finasteride 1mg tablet

Patient alert card

Fingolimod

Amarox Limited

{pdf_link}

Fingolimod patient guide

Fingolimod patient guide
{pdf_link}

Fingolimod patient information-Pregnancy-Specific Patient Reminder Card

Fingolimod patient information-Pregnancy-Specific Patient Reminder Card
{pdf_link}

Fingolimod prescriber's checklist

{healthcare_pro_orange} For Healthcare Professionals
Fingolimod prescriber's checklist

Dr. Reddy's Laboratories (UK) Ltd

{pdf_link}

Fingolimod - Patients Information Booklet - for Patients

This patient booklet contains important things to remember about Fingolimod treatment for patients, parents and caregivers
{pdf_link}

Fingolimod - Pregnancy-Specific Patient Reminder Card - for patients

This reminder card contains pregnancy-specific safety information about Fingolimod treatment
{pdf_link}

Fingolimod - Prescribers checklist - for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals
This checklist outlines important points to remember before, during and after treatment

Flynn Pharma Ltd

{external_link}

Fingolimod Patient Information Booklet

Important things to remember about Fingolimod treatment for patients, parents and caregivers
{external_link}

Fingolimod Pregnancy-Specific Patient Reminder Card

Fingolimod Pregnancy-specific patient reminder card
{external_link}

Fingolimod Prescribers Checklist

{healthcare_pro_orange} For Healthcare Professionals
Fingolimod Prescriber’s Checklist – Important points to remember before, during and after treatment

Glenmark Pharmaceuticals Europe Ltd

{pdf_link}

Fingolimod Pregnancy-Specific Patient Reminder Card

Fingolimod Pregnancy-Specific Patient Reminder Card Reminder card Pregnancy-Specific for patients that have been prescribed fingolimod. It contains information on before starting fingolimod treatment, while you are taking fingolimod and after stopping fingolimod treatment.
{pdf_link}

Important things for Patients, Parents and Caregivers to remember about treatment on Fingolimod

Booklet for patients that have been prescribed fingolimod. It contains important information for patients, parents and caregivers including what is multiple sclerosis(MS), how does Fingolimod work, how to take fingolimod the right way and why monitoring your treatment is important.
{pdf_link}

Prescriber’s Checklist: Important Points to Remember before, during and after treatment on Fingolimod

{healthcare_pro_orange} For Healthcare Professionals
The checklist is intended to assist in the management of patients on fingolimod. Key steps and considerations while starting, continuing, or discontinuing treatment are provided.

Mylan

{pdf_link}

Fingolimod Patient Parent and Caregiver Guide

Important things to remember about Fingolimod treatment for patients, parents and caregivers
{pdf_link}

Fingolimod Physicians Checklist

{healthcare_pro_orange} For Healthcare Professionals
For HCPs: Important points to remember before, during and after treatment with Fingolimod
{pdf_link}

Fingolimod Pregnancy-Specific Patient Reminder Card

Pregnancy-Specific Patient Reminder Card for Fingolimod

Ranbaxy (UK) Limited a Sun Pharmaceutical Company

{pdf_link}

Dissemination of educational materials for Fingolimod SUN

{healthcare_pro_orange} For Healthcare Professionals
Dissemination of educational materials for Fingolimod SUN Communication plan
{pdf_link}

Fingolimod healthcare professional information

{healthcare_pro_orange} For Healthcare Professionals
Fingolimod SUN Prescriber’s checklist Important points to remember before, during and after treatment
{pdf_link}

Fingolimod patient guide

{healthcare_pro_orange} For Healthcare Professionals
Important things to remember about Fingolimod SUN treatment for patients, parents and caregivers
{pdf_link}

Fingolimod patient information

{healthcare_pro_orange} For Healthcare Professionals
Fingolimod SUN Pregnancy-Specific Patient Reminder Card

Sandoz Limited

{pdf_link}

Fingolimod Patient and Caregivers Guide

Fingolimod Patient and Caregivers Guide - Important things to remember about Fingolimod treatment for patients, parents and caregivers
{pdf_link}

Fingolimod Pregnancy-specific patient reminder card

Fingolimod Pregnancy-specific patient reminder card
{pdf_link}

Fingolimod Prescriber's Checklist

{healthcare_pro_orange} For Healthcare Professionals
Fingolimod prescriber’s checklist Important points to remember before, during and after treatment

Teva UK Limited

{pdf_link}

Fingolimod Teva Patient Information Guide

Fingolimod Teva Patient Information Guide
{pdf_link}

Fingolimod Teva Patient Reminder Card

Fingolimod Teva Patient Reminder Card
{pdf_link}

Fingolimod Teva Prescriber's Checklist

{healthcare_pro_orange} For Healthcare Professionals
Fingolimod Teva Prescriber's Checklist

Tillomed Laboratories Ltd

{pdf_link}

Fingolimod - Pregnancy-Specific Patient Reminder Card - for patients

Pregnancy-specific patient reminder card for those on fingolimod treatment
{pdf_link}

Fingolimod Patient, Parent, Caregiver Guide

Important things to remember about Fingolimod treatment for patients, parents and caregivers
{pdf_link}

Fingolimod Prescribers checklist - for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals
This checklist outlines important points to remember before, during and after treatment

Zentiva

{pdf_link}

Fingolimod Patient Card

Pregnancy Specific Patient Reminder Card
{pdf_link}

Fingolimod Patient Guide

Important things to remember about Fingolimod Zentiva 0.5 mg hard capsules treatment for patients, parents and caregivers
{pdf_link}

Fingolimod Prescribers Checklist

Important points to remember before, during and after treatment

Fintepla

UCB Pharma Limited

{pdf_link}

Fintepla Patients and Caregivers alert card

This guide contains information about the risks associated with FINTEPLA and the tests and checks that are needed during treatment with fenfluramine.
{pdf_link}

Fintepla Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals
This guide is developed to increase awareness and educate prescribers about the risks associated with the use of Fintepla and to inform the prescribing physicians of the need to conduct periodic cardiac monitoring in patients taking Fintepla.

Flixabi

Biogen Biosimilars

{pdf_link}

Flixabi Patient Reminder Card

This Reminder Card contains important safety information that patients need to be aware of before and during treatment with Flixabi.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.